| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/21/2001 | EP1083875A1 Small molecule carbamate or urea hair growth compositions and uses |
| 03/21/2001 | EP1083874A1 Small molecule pipecolic acid derivative hair growth compositions and uses |
| 03/21/2001 | EP1083873A1 Heterocyclic thioester and ketone hair growth compositions and uses |
| 03/21/2001 | EP1083872A1 Pipecolic acid derivative hair growth compositions and uses |
| 03/21/2001 | EP1083856A1 Topical transdermal treatments |
| 03/21/2001 | EP0938310A4 Anti-viral compounds |
| 03/21/2001 | EP0762877B1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof |
| 03/21/2001 | EP0738275B9 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 03/21/2001 | EP0717616B1 Process for conditioning substances |
| 03/21/2001 | EP0714284B1 Use of oligosaccharides for the prevention and treatment of tissue ageing |
| 03/21/2001 | EP0681569B1 Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| 03/21/2001 | CN1288470A Synthetic polysaccharides, their method of prodn. and pharmaceutical compositions contg. same |
| 03/21/2001 | CN1288465A Triazolo-pyridzine derivatives as ligands for GABA receptors |
| 03/21/2001 | CN1288464A 4-(2-keto-1-benzimidazolynyl) pipeidine compounds as ORL-1 receptor |
| 03/21/2001 | CN1288463A Alternate method for acylating 10-deactetylbaccatin III selectively at the C-10 position |
| 03/21/2001 | CN1288462A Oxazolidinone combinatorial libraries, compositions and method of prepn. |
| 03/21/2001 | CN1288458A Triazepinones, process for their prepn. and their therapeutic application |
| 03/21/2001 | CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion |
| 03/21/2001 | CN1288456A Substances capable of inducing appotosis |
| 03/21/2001 | CN1288388A Stabilization of lipid DNA formulations during nebulization |
| 03/21/2001 | CN1288385A Pharmaceutical formulations and processes for their prepn. |
| 03/21/2001 | CN1288383A St. John's wort and methyl donor composition and uses thereof |
| 03/21/2001 | CN1288381A Fat-binding polymers |
| 03/21/2001 | CN1288380A Utilization of powder prepns. contg. hydroxypyridones treating LEG ulcer and decubitus ulcers |
| 03/21/2001 | CN1288379A Method and kits for treating vulvovaginal candidiasis with micronazole nitrate |
| 03/21/2001 | CN1288378A Celecoxib compositions |
| 03/21/2001 | CN1288377A Patassium channel activators |
| 03/21/2001 | CN1288376A Transdermal therapeutic system (TTS) contg. oxybutynin |
| 03/21/2001 | CN1288375A TTS contg. an antioxidant |
| 03/21/2001 | CN1288372A Fluorometholone suspension eye drops |
| 03/21/2001 | CN1288012A Antisense nucleic acid pointing at urokinase type plasminogen activating agent gene for inhibiting carcer |
| 03/21/2001 | CN1288008A Sulfur-bearing phospho acid compound, pharmaceutical composite and use in prepn. of medicine |
| 03/21/2001 | CN1288007A 6-carbonyl-3-(4-[2-(pierid-1-yl)elhoyl]phenoxy)-2(4-methoxylphenyl) benzo[b]thiophene salt crystal |
| 03/21/2001 | CN1288006A Soya total flavone, its prepn. method and use thereof |
| 03/21/2001 | CN1287856A Compound medicinal powder for treating tuberculosis |
| 03/21/2001 | CN1287836A Doukey-hide gelatin capsule |
| 03/21/2001 | CN1287835A Medical ointment for periodontal disease |
| 03/21/2001 | CN1287834A Cyclodextrin encapsulated freeze-dried powder injection of prostaglandin E1 |
| 03/21/2001 | CN1287833A Zinc enriched medicine |
| 03/21/2001 | CN1287832A 樟脑搽剂 Camphor liniment |
| 03/21/2001 | CN1063445C Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds |
| 03/21/2001 | CN1063444C Stable crystalline (65)-and (GR)-tetrahydrofolic acid |
| 03/21/2001 | CN1063439C N-substituted 2-hetero cyclicbutanol |
| 03/21/2001 | CN1063438C Alkenyl-benzoyl guanidine derivant, prepn. method and use thereof |
| 03/21/2001 | CN1063437C Fluorophenyl sbstd. alkenylc arboxylic acid guanidine its preparation method applied as medicine and diagnosis agent and medicine containing the compound |
| 03/21/2001 | CN1063436C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines prepn. method and usage thereof |
| 03/21/2001 | CN1063430C Ethanolamine derivatives |
| 03/21/2001 | CN1063333C Liniment and its prepn. method |
| 03/21/2001 | CN1063323C Mehtod for treatment of psoriasis |
| 03/21/2001 | CN1063322C Aqueous liquid composition for eye external use as eyedrops |
| 03/21/2001 | CN1063321C Medicaments aerosol prepn. and preparing method therefor and releasing apparatus therefor |
| 03/21/2001 | CN1063311C Stable microemulsions of Certain 3-isothiazolone compounds |
| 03/21/2001 | CA2319967A1 Compositions containing proanthocyanidin and a vitamin b6 derivative or a salt thereof |
| 03/21/2001 | CA2319842A1 Use of alverine to reduce wrinkles |
| 03/21/2001 | CA2282982A1 Local delivery of 17 - beta estradiol during balloon angioplasty for preventing restenosis |
| 03/20/2001 | US6204415 2,2-difluoro-2-ethylthioacetophenone derivatives of given formula which have use as intermediates to antimycotic agents |
| 03/20/2001 | US6204388 Using blocking agent |
| 03/20/2001 | US6204362 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 03/20/2001 | US6204296 Patient oxygenation using stabilized fluorocarbon emulsions |
| 03/20/2001 | US6204295 Halogenated triphenylethylene derivatives,protection of human organs, from oxidative damage induced by lipid peroxidation and inhibiting the production of reactive oxygen species by activated neutrophils |
| 03/20/2001 | US6204294 IL-8 receptor antagonists |
| 03/20/2001 | US6204292 Bicyclic metabotropic glutamate receptor ligands |
| 03/20/2001 | US6204291 Effective amount of l-carnitine. |
| 03/20/2001 | US6204290 Treating a hypercholesteremic, thrombotic, oxidative, inflammatory, or immunoregulatory disease |
| 03/20/2001 | US6204289 Treating a disorder involving memory loss, cognitive problems, and/or dementia |
| 03/20/2001 | US6204287 Treating vision defects |
| 03/20/2001 | US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols |
| 03/20/2001 | US6204285 Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolate |
| 03/20/2001 | US6204284 Alcohol or cocaine abuse |
| 03/20/2001 | US6204283 Parasitic mite control on beneficial insects |
| 03/20/2001 | US6204281 Treatment or prevention of hypertension associated with diabetes with (i) the at1-antagonist valsartan or salt thereof and (ii) the calcium channel blocker verapamil or salt thereof |
| 03/20/2001 | US6204280 Oxazolidinone derivative, anticoagulant |
| 03/20/2001 | US6204278 Anilide compounds, including use thereof in ACAT inhibitition |
| 03/20/2001 | US6204277 Treating diabetes |
| 03/20/2001 | US6204276 Dicarboxylic germanium complex and its therapeutic use |
| 03/20/2001 | US6204273 Treatment of androgenic sensitive disorders such as acne vulgaris, seborrhea, female hirsutism, male pattern baldness, and benign prostatic hyperplasia. |
| 03/20/2001 | US6204272 Considerable improvement in wound healing. |
| 03/20/2001 | US6204271 Analgesic composition and method for using same |
| 03/20/2001 | US6204270 Anti-tnf-alpha agent and a mucoadhesive delivery system, wherein the anti-tnf-alpha agent comprises a tnf-alpha neutralizing agent. |
| 03/20/2001 | US6204267 Methods of modulating serine/thereonine protein kinase function with quinazoline-based compounds |
| 03/20/2001 | US6204266 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204259 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/20/2001 | US6204258 Enhancing hair growth or treating alopecia in a subject uses topically administered estrogen receptor antagonists. |
| 03/20/2001 | US6204257 Drug delivery |
| 03/20/2001 | US6204255 Molar ratio of sodium valproate to cyclodextrin within the range of from 1:0.01 to 1:0.09. |
| 03/20/2001 | US6204249 For the treatment or prophylaxis of virus infections such as those caused by herpes viruses. |
| 03/20/2001 | US6204248 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 03/20/2001 | US6204245 Treatment of narcolepsy with immunosuppressants |
| 03/20/2001 | US6204244 Amino acid compositions and use thereof in immunosuppression |
| 03/20/2001 | US6204055 Antisense inhibition of Fas mediated signaling |
| 03/20/2001 | US6204053 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204042 Isolated polynucleotide segment |
| 03/20/2001 | US6204032 Method for producing pravastatin precursor, ML-236B |
| 03/20/2001 | US6204022 Low-toxicity human interferon-alpha analogs |
| 03/20/2001 | US6204015 Aminopeptidase from staphylococcus aureus |
| 03/20/2001 | US6204001 Methods for determining compounds capable of inhibiting the activities of the Ha-Ras oncongene |